Helicobacter pylori Infection Combined with OLGA and OLGIM Staging Systems for Risk Assessment of Gastric Cancer: A Retrospective Study in Eastern China

References

• Smyth EC, Nilsson M, Grabsch HI, van Grieken NCT, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–648. doi:10.1016/S0140-6736(20)31288-5
   PubMed Web of Science ®Google Scholar
• Thrift AP, El-Serag HB. Burden of gastric cancer. Clin Gastroenterol Hepatol. 2020;18(3):534–542. doi:10.1016/j.cgh.2019.07.045
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Cai Q, Zhu C, Yuan Y, et al. Development and validation of a prediction rule for estimating gastric cancer risk in the Chinese high-risk population: a nationwide multicentre study. Gut. 2019;68(9):1576–1587. doi:10.1136/gutjnl-2018-317556
   PubMed Web of Science ®Google Scholar
• Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52(24):6735–6740.
   PubMed Web of Science ®Google Scholar
• Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer. Aliment Pharmacol Ther. 1999;13(Suppl 1):3–11. doi:10.1046/j.1365-2036.1999.00002.x
   PubMed Web of Science ®Google Scholar
• de Vries AC, van Grieken NC, Looman CW, et al. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology. 2008;134(4):945–952. doi:10.1053/j.gastro.2008.01.071
   PubMed Web of Science ®Google Scholar
• Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol. 1996;20:23–30. doi:10.1097/00000478-199600001-00004
   Web of Science ®Google Scholar
• Rugge M, Meggio A, Pennelli G, et al. Gastritis staging in clinical practice: the OLGA staging system. Gut. 2007;56(5):631–636. doi:10.1136/gut.2006.106666
   PubMed Web of Science ®Google Scholar
• Capelle LG, de Vries AC, Haringsma J, et al. The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest Endosc. 2010;71(7):1150–1158. doi:10.1016/j.gie.2009.12.029
   PubMed Web of Science ®Google Scholar
• Rugge M, de Boni M, Pennelli G, et al. Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment Pharmacol Ther. 2010;31(10):1104–1111. doi:10.1111/j.1365-2036.2010.04277.x
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, Fassan M, et al. OLGA gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients. Am J Gastroenterol. 2018;113(11):1621–1628. doi:10.1038/s41395-018-0353-8
   PubMed Web of Science ®Google Scholar
• Pimentel-Nunes P, Libanio D, Marcos-Pinto R, et al. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy. 2019;51(4):365–388. doi:10.1055/a-0859-1883
   PubMed Web of Science ®Google Scholar
• Annibale B, Esposito G, Lahner E. A current clinical overview of atrophic gastritis. Expert Rev Gastroenterol Hepatol. 2020;14(2):93–102. doi:10.1080/17474124.2020.1718491
   PubMed Web of Science ®Google Scholar
• Chen XZ, Huang CZ, Hu WX, Ying L, Yao XQ. Gastric cancer screening by combined determination of serum helicobacter pylori antibody and pepsinogen concentrations: abc method for gastric cancer screening. Chin Med J. 2018;131(010):1232–1239. doi:10.4103/0366-6999.231512
   PubMed Web of Science ®Google Scholar
• Kuipers EJ. In through the out door serology for atrophic gastritis. Eur J Gastroenterol Hepatol. 2003;15:877–879. doi:10.1097/00042737-200308000-00007
   PubMed Web of Science ®Google Scholar
• Rugge M, Fassan M, Graham DY. Clinical guidelines: secondary prevention of gastric cancer. Nat Rev Gastroenterol Hepatol. 2012;9(3):128–129. doi:10.1038/nrgastro.2012.19
   PubMed Web of Science ®Google Scholar
• Ranjbar R, Behzadi P, Farshad S. Advances in diagnosis and treatment of Helicobacter pylori infection. Acta Microbiol Immunol Hung. 2017;64(3):273–292. doi:10.1556/030.64.2017.008
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, Graham DY, et al. Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment. Gut. 2016;65(5):721–725. doi:10.1136/gutjnl-2015-310846
   PubMed Web of Science ®Google Scholar
• Wang Z, Graham DY, Khan A, et al. Incidence of gastric cancer in the USA during 1999 to 2013: a 50-state analysis. Int J Epidemiol. 2018;47(3):966–975. doi:10.1093/ije/dyy055
   PubMed Web of Science ®Google Scholar
• Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney system international workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161–1181.
   PubMed Web of Science ®Google Scholar
• Rugge M, Genta RM, Group O. Staging gastritis: an international proposal. Gastroenterology. 2005;129(5):1807–1808. doi:10.1053/j.gastro.2005.09.056
   PubMed Web of Science ®Google Scholar
• Cho SJ, Choi IJ, Kook MC, et al. Staging of intestinal- and diffuse-type gastric cancers with the OLGA and OLGIM staging systems. Aliment Pharmacol Ther. 2013;38(10):1292–1302. doi:10.1111/apt.12515
   PubMed Web of Science ®Google Scholar
• Lee JWJ, Zhu F, Srivastava S, et al. Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP). Gut. 2021;71(5):854–863. doi:10.1136/gutjnl-2021-324057
   PubMed Web of Science ®Google Scholar
• Wang X, Lu B, Meng L, Fan Y, Zhang S, Li M. The correlation between histological gastritis staging- ‘OLGA/OLGIM’ and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China. Scand J Gastroenterol. 2017;52(8):822–827. doi:10.1080/00365521.2017.1315739
   PubMed Web of Science ®Google Scholar
• Yue H, Shan L, Bin L. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer. 2018;21(4):579–587. doi:10.1007/s10120-018-0812-3
   PubMed Web of Science ®Google Scholar
• Miki K. Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - “ABC method”. Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(7):405–414. doi:10.2183/pjab.87.405
   PubMed Web of Science ®Google Scholar
• Kawaguchi H, Haruma K, Komoto K, Yoshihara M, Sumii K, Kajiyama G. Helicobacter pylori infection is the major risk factor for atrophic gastritis. Gastroenterology. 1996;108(5):959–962.
   Google Scholar
• Kim N, Park YS, Cho SI, et al. Prevalence and risk factors of atrophic gastritis and intestinal metaplasia in a Korean population without significant gastroduodenal disease. Helicobacter. 2008;13:4. doi:10.1111/j.1523-5378.2008.00604.x
   Web of Science ®Google Scholar
• Ohkuma K, Okada M, Murayama H, et al. Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia. J Gastroenterol Hepatol. 2000;15(10):1105–1112. doi:10.1046/j.1440-1746.2000.02305.x
   PubMed Web of Science ®Google Scholar
• Miki K, Urita Y. Using serum pepsinogens wisely in a clinical practice. J Dig Dis. 2007;8(1):8–14. doi:10.1111/j.1443-9573.2007.00278.x
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M, Areia M, Vries ACD, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Archiv. 2012;44(1):74–94.
   Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-The Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. doi:10.1136/gutjnl-2016-312288
   PubMed Web of Science ®Google Scholar
• Sugano K, Tack J, Kuipers EJ, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64(9):1353–1367. doi:10.1136/gutjnl-2015-309252
   PubMed Web of Science ®Google Scholar
• Hedayati MA, Salavati S. Transcriptional profile of helicobacter pylori virulence genes in patients with gastritis and gastric cancer. Can J Infect Dis Med Microbiol. 2021;2021:1309519. doi:10.1155/2021/1309519
   PubMed Web of Science ®Google Scholar
• Yun CY, Kim N, Lee J, et al. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors. Helicobacter. 2018;23(6):e12542. doi:10.1111/hel.12542
   PubMed Web of Science ®Google Scholar
• Maura G, Chaignot C, Weill A, Alla F, Heard I. Cervical cancer screening and subsequent procedures in women under the age of 25 years between 2007 and 2013 in France: a nationwide French healthcare database study. Eur J Cancer Prev. 2018;27(5):479–485. doi:10.1097/CEJ.0000000000000360
   PubMed Web of Science ®Google Scholar
• Miki K. Gastric cancer screening using the serum pepsinogen test method. Gastric Cancer. 2006;9(4):245–253. doi:10.1007/s10120-006-0397-0
   PubMedGoogle Scholar
• Mizuno S, Kobayashi M, Tomita S, et al. Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. Gastric Cancer. 2009;12(3):158–163. doi:10.1007/s10120-009-0522-y
   PubMed Web of Science ®Google Scholar
• Huang YK, Yu JC, Kang WM, et al. Significance of serum pepsinogens as a biomarker for gastric cancer and atrophic gastritis screening: a systematic review and meta-analysis. PLoS One. 2015;10(11):e0142080. doi:10.1371/journal.pone.0142080
   PubMed Web of Science ®Google Scholar
• Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46(7):657–667. doi:10.1111/apt.14248
   PubMed Web of Science ®Google Scholar